InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $1.220 0.125 (9.29%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 OncoSil Medical Investor Update - July 2015 8 Jul 2015 9:14AM $0.100 $1.220 risen by 1,120%
$38 CMO appointed in lead-up to Commercialisation 4 Jun 2015 9:38AM $0.115 $1.220 risen by 960.87%
$38 OncoSil Medical - Investor Presentation June 2015 3 Jun 2015 10:35AM $0.120 $1.220 risen by 916.67%
$38 Prof Pierce Chow Announcement 21 May 2015 9:32AM $0.110 $1.220 risen by 1,009.09%
$38 OncoSil European Commercialisation On-Track 18 May 2015 9:52AM $0.115 $1.220 risen by 960.87%
$38 Appendix 3B 11 May 2015 11:22AM $0.100 $1.220 risen by 1,120%
$38 Final Director's Interest Notice 11 May 2015 10:14AM $0.100 $1.220 risen by 1,120%
$38 Proactive Investor Presentation May 2015 5 May 2015 2:07PM $0.115 $1.220 risen by 960.87%
$38 OncoSil Medical Investor Presentation announcement 5 May 2015 2:01PM $0.115 $1.220 risen by 960.87%
$38 OncoSil Medical - Director resignation 4 May 2015 9:26AM $0.105 $1.220 risen by 1,061.90%
$38 Appendix 4C - quarterly 28 Apr 2015 8:26AM $0.087 $1.220 risen by 1,302.30%
$38 OncoSil Medical ISO Certification Announcement 27 Apr 2015 8:26AM $0.082 $1.220 risen by 1,387.80%
$38 OncoSil HCC Announcement 16 Mar 2015 9:20AM n/a $1.220 n/a
$38 Half Year Accounts 26 Feb 2015 4:36PM n/a $1.220 n/a
$38 Global Registration Plan advances 25 Feb 2015 9:34AM n/a $1.220 n/a
$38 Global Registration Plan advances 25 Feb 2015 9:34AM n/a $1.220 n/a
$38 Appendix 4C - quarterly 27 Jan 2015 5:06PM n/a $1.220 n/a
$38 R&D Incentive Approval 16 Dec 2014 9:23AM $0.082 $1.220 risen by 1,387.80%
$38 Appointment of CEO 11 Nov 2014 8:30AM $0.110 $1.220 risen by 1,009.09%
$38 Appendix 4C - Quarterly 28 Oct 2014 9:15AM $0.105 $1.220 risen by 1,061.90%
$38 Board and senior management restructure 9 Sep 2014 2:46PM $0.130 $1.220 risen by 838.46%
$38 Appendix 4E 29 Aug 2014 9:22AM $0.105 $1.220 risen by 1,061.90%
$38 Appendix 4C - quarterly 31 Jul 2014 11:29AM $0.130 $1.220 risen by 838.46%
$38 GMP manufacturing process finalised for OncoSil Medical 16 Jul 2014 9:23AM $0.105 $1.220 risen by 1,061.90%
$38 Ethics Approval Granted for OncoSil in Pancreatic Cancer 15 Jul 2014 9:08AM $0.099 $1.220 risen by 1,132.32%

751 - 775 of 791 results

Page 31 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.